Market

To develop innovative treatments in inflammation and pain management

Efficacy and safety of Optidoz has been established through the CONTROL-Hypertension clinical study

Ranbaxy to market in India and other emerging markets, after approval

CANMAb, developed jointly by Biocon and Mylan under a global partnership

Report mentions that the government is impeding the development of its pharma sector, mainly due to extensive bureaucracy and poor…

The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe

HumaPen Savvio is designed to resemble a small personal accessory rather than a medical device to help manage diabetes discreetly

The IPM market grew for the second consecutive month, clocking a growth of 8.2 per cent

Slated to be held from March 4-6, 2014, it would connect key stakeholders, to facilitate learning, as well as sharing of…

40 member business delegation from Argentina to participate at BioAsia